Online inquiry

IVTScrip™ mRNA-Anti-RABVgp4, CR57(Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) (CAT#: GTTS-WQ6250MR)

This product GTTS-WQ6250MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP. It ecodes the monoclonal antibody that targets RABVgp4 gene. The antibody can be applied in Rabies research.

Specifications
Product type	mRNA
Modified bases	5-Methyl-CTP
5' Cap	Cap 1
Species	Homo sapiens
RefSeq	NP_056796.1
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	1489856
UniProt ID	P08667

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-RABVgp4, CR57(Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) (GTTS-WQ6250MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ9740MR	IVTScrip™ mRNA-Anti-TFRC, JR-141(Cap 0, Pseudo-UTP, 30 nt-poly(A))	mRNA	JR-141
GTTS-WQ6561MR	IVTScrip™ mRNA-Anti-TNF, D2E7(Cap 0, 5-Methyl-CTP, 30 nt-poly(A))	mRNA	D2E7
GTTS-WQ15860MR	IVTScrip™ mRNA-Anti-CD19, XmAb5871(Cap 1, 5-Methoxy-UTP, 120 nt-poly(A))	mRNA	XmAb5871
GTTS-WQ14411MR	IVTScrip™ mRNA-Anti-IL2RA, RO 24-7375(Cap 0, Pseudo-UTP, 30 nt-poly(A))	mRNA	RO 24-7375
GTTS-WQ12880MR	IVTScrip™ mRNA-Anti-TNF, OPRX-106(Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))	mRNA	OPRX-106
GTTS-WQ3517MR	IVTScrip™ mRNA-Anti-APP, BART(Cap 1, Pseudo-UTP, 30 nt-poly(A))	mRNA	BART
GTTS-WQ2706MR	IVTScrip™ mRNA-Anti-CD19&CD3E, AMG103(Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	AMG103
GTTS-WQ9827MR	IVTScrip™ mRNA-Anti-ICOS, JTX-2011(Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))	mRNA	JTX-2011

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST